73/100B319.68
USD
4.16
(1.32%)
Market Open
Last updated: · Delayed 15 min
Fair value297.15Plus+8%228Price 319.68499
Q4 FY2026 · Earnings report
EPS estimate 3.01Revenue estimate 1.76B
Q4 FY2026 · Earnings report
EPS estimate 3.01Revenue estimate 1.76B
CME Group price to sales (P/S) ratioWhat is the P/S ratio? The price-to-sales ratio compares a company's market value with its revenue over the last year: what you pay for each dollar of sales.
CME Group's P/S ratio is 16.41: its market cap of 114.42B USD over revenue of 6.97B USD in the last twelve months.
- Today
- 16.41
- Average, 5 years
- 14.62
- Low, 5 years
- 11.62
- High, 5 years
- 19.26
P/S ratio = market cap ÷ revenue (last 12 months) = 114.42B ÷ 6.97B = 16.41
Each day's market cap over the revenue of the last four quarters reported by that day.
P/S ratio by year and by quarter
| Fiscal year | Period ending | P/S ratio | Market cap | Revenue |
|---|---|---|---|---|
| Today | 16.41 | 114.42B | 6.97B | |
| FY2025 | 31 Dec 2025 | 15.06 | 98.21B | 6.52B |
| FY2024 | 31 Dec 2024 | 13.61 | 83.46B | 6.13B |
| FY2023 | 31 Dec 2023 | 13.55 | 75.61B | 5.58B |
| FY2022 | 31 Dec 2022 | 12.02 | 60.32B | 5.02B |
| FY2021 | 31 Dec 2021 | 17.46 | 81.87B | 4.69B |
| FY2020 | 31 Dec 2020 | 13.34 | 65.13B | 4.88B |
| FY2019 | 31 Dec 2019 | 14.73 | 71.69B | 4.87B |
| FY2018 | 31 Dec 2018 | 14.94 | 64.40B | 4.31B |
| FY2017 | 31 Dec 2017 | 13.57 | 49.47B | 3.64B |
| FY2016 | 31 Dec 2016 | 10.83 | 38.93B | 3.60B |
| FY2015 | 31 Dec 2015 | 9.16 | 30.46B | 3.33B |
| FY2014 | 31 Dec 2014 | 9.52 | 29.65B | 3.11B |
| FY2013 | 31 Dec 2013 | 8.89 | 26.10B | 2.94B |
| FY2012 | 31 Dec 2012 | 5.76 | 16.78B | 2.91B |
| FY2011 | 31 Dec 2011 | 4.94 | 16.21B | 3.28B |
| FY2010 | 31 Dec 2010 | 7.10 | 21.33B | 3.00B |
| FY2009 | 31 Dec 2009 | 8.53 | 22.30B | 2.61B |
| FY2008 | 31 Dec 2008 | 4.77 | 12.22B | 2.56B |
| FY2007 | 31 Dec 2007 | 17.09 | 30.02B | 1.76B |
| FY2006 | 31 Dec 2006 | 16.23 | 17.69B | 1.09B |
| FY2005 | 31 Dec 2005 | 14.17 | 12.61B | 889.77M |
| FY2004 | 31 Dec 2004 | 10.63 | 7.67B | 721.55M |
| FY2003 | 31 Dec 2003 | 4.41 | 2.37B | 536.04M |
| FY2002 | 31 Dec 2002 | 2.70 | 1.27B | 469.08M |
| FY2001 | 31 Dec 2001 | 3.11 | 1.23B | 396.63M |
| FY2000 | 31 Dec 2000 | 5.45 | 1.23B | 226.55M |
| Quarter | Period ending | P/S ratio | Market cap | Revenue |
|---|---|---|---|---|
| Q3 FY2026 | 30 Sept 2026 | 13.45 | 93.79B | 6.97B |
| Q2 FY2026 | 30 Jun 2026 | 11.74 | 79.50B | 6.77B |
| Q1 FY2026 | 31 Mar 2026 | 15.70 | 106.12B | 6.76B |
| Q4 FY2025 | 31 Dec 2025 | 15.06 | 98.21B | 6.52B |
| Q3 FY2025 | 30 Sept 2025 | 15.19 | 97.17B | 6.40B |
| Q2 FY2025 | 30 Jun 2025 | 15.38 | 99.12B | 6.44B |
| Q1 FY2025 | 31 Mar 2025 | 15.18 | 95.40B | 6.28B |
| Q4 FY2024 | 31 Dec 2024 | 13.61 | 83.46B | 6.13B |
| Q3 FY2024 | 30 Sept 2024 | 13.12 | 79.30B | 6.04B |
| Q2 FY2024 | 30 Jun 2024 | 12.12 | 70.25B | 5.80B |
| Q1 FY2024 | 31 Mar 2024 | 13.54 | 76.17B | 5.63B |
| Q4 FY2023 | 31 Dec 2023 | 13.56 | 75.65B | 5.58B |
| Q3 FY2023 | 30 Sept 2023 | 13.44 | 71.88B | 5.35B |
| Q2 FY2023 | 30 Jun 2023 | 12.70 | 66.51B | 5.24B |
| Q1 FY2023 | 31 Mar 2023 | 13.44 | 68.74B | 5.11B |
| Q4 FY2022 | 31 Dec 2022 | 12.02 | 60.35B | 5.02B |
| Q3 FY2022 | 30 Sept 2022 | 12.81 | 63.54B | 4.96B |
| Q2 FY2022 | 30 Jun 2022 | 15.17 | 73.41B | 4.84B |
| Q1 FY2022 | 31 Mar 2022 | 17.83 | 85.30B | 4.78B |
| Q4 FY2021 | 31 Dec 2021 | 17.47 | 81.92B | 4.69B |
| Q3 FY2021 | 30 Sept 2021 | 14.93 | 69.30B | 4.64B |
| Q2 FY2021 | 30 Jun 2021 | 16.52 | 76.19B | 4.61B |
| Q1 FY2021 | 31 Mar 2021 | 15.85 | 73.14B | 4.61B |
| Q4 FY2020 | 31 Dec 2020 | 13.35 | 65.18B | 4.88B |
| Q3 FY2020 | 30 Sept 2020 | 12.16 | 59.86B | 4.92B |
| Q2 FY2020 | 30 Jun 2020 | 11.36 | 58.14B | 5.12B |
| Q1 FY2020 | 31 Mar 2020 | 11.86 | 61.82B | 5.21B |
| Q4 FY2019 | 31 Dec 2019 | 14.74 | 71.75B | 4.87B |
| Q3 FY2019 | 30 Sept 2019 | 15.20 | 75.49B | 4.97B |
| Q2 FY2019 | 30 Jun 2019 | 15.28 | 70.19B | 4.59B |
| Q1 FY2019 | 31 Mar 2019 | 13.57 | 59.44B | 4.38B |
| Q4 FY2018 | 31 Dec 2018 | 15.32 | 66.02B | 4.31B |
| Q3 FY2018 | 30 Sept 2018 | 14.89 | 59.17B | 3.97B |
| Q2 FY2018 | 30 Jun 2018 | 14.05 | 55.65B | 3.96B |
| Q1 FY2018 | 31 Mar 2018 | 14.35 | 54.88B | 3.82B |
| Q4 FY2017 | 31 Dec 2017 | 13.59 | 49.53B | 3.64B |
| Q3 FY2017 | 30 Sept 2017 | 12.57 | 45.96B | 3.66B |
| Q2 FY2017 | 30 Jun 2017 | 11.75 | 42.40B | 3.61B |
| Q1 FY2017 | 31 Mar 2017 | 11.20 | 40.19B | 3.59B |
| Q4 FY2016 | 31 Dec 2016 | 10.85 | 39.00B | 3.60B |
| Q3 FY2016 | 30 Sept 2016 | 10.09 | 35.29B | 3.50B |
| Q2 FY2016 | 30 Jun 2016 | 9.37 | 32.85B | 3.50B |
| Q1 FY2016 | 31 Mar 2016 | 9.47 | 32.37B | 3.42B |
| Q4 FY2015 | 31 Dec 2015 | 9.17 | 30.52B | 3.33B |
| Q3 FY2015 | 30 Sept 2015 | 9.30 | 31.19B | 3.35B |
| Q2 FY2015 | 30 Jun 2015 | 9.57 | 31.27B | 3.27B |
| Q1 FY2015 | 31 Mar 2015 | 10.00 | 31.79B | 3.18B |
| Q4 FY2014 | 31 Dec 2014 | 9.55 | 29.72B | 3.11B |
| Q3 FY2014 | 30 Sept 2014 | 9.04 | 26.74B | 2.96B |
| Q2 FY2014 | 30 Jun 2014 | 8.14 | 23.70B | 2.91B |
| Q1 FY2014 | 31 Mar 2014 | 8.25 | 24.72B | 3.00B |
| Q4 FY2013 | 31 Dec 2013 | 8.91 | 26.18B | 2.94B |
| Q3 FY2013 | 30 Sept 2013 | 8.45 | 24.58B | 2.91B |
| Q2 FY2013 | 30 Jun 2013 | 8.83 | 25.43B | 2.88B |
| Q1 FY2013 | 31 Mar 2013 | 7.08 | 20.23B | 2.86B |
| Q4 FY2012 | 31 Dec 2012 | 5.77 | 16.81B | 2.91B |
| Q3 FY2012 | 30 Sept 2012 | 6.33 | 18.92B | 2.99B |
| Q2 FY2012 | 30 Jun 2012 | 5.58 | 17.75B | 3.18B |
| Q1 FY2012 | 31 Mar 2012 | 5.94 | 19.14B | 3.22B |
| Q4 FY2011 | 31 Dec 2011 | 4.91 | 16.11B | 3.28B |
| Q3 FY2011 | 30 Sept 2011 | 4.95 | 16.38B | 3.31B |
| Q2 FY2011 | 30 Jun 2011 | 6.15 | 19.47B | 3.17B |
| Q1 FY2011 | 31 Mar 2011 | 6.42 | 20.16B | 3.14B |
| Q4 FY2010 | 31 Dec 2010 | 7.16 | 21.50B | 3.00B |
| Q3 FY2010 | 30 Sept 2010 | 5.96 | 17.33B | 2.91B |
| Q2 FY2010 | 30 Jun 2010 | 6.54 | 18.46B | 2.83B |
| Q1 FY2010 | 31 Mar 2010 | 7.87 | 20.94B | 2.66B |
| Q4 FY2009 | 31 Dec 2009 | 8.52 | 22.25B | 2.61B |
| Q3 FY2009 | 30 Sept 2009 | 7.76 | 20.46B | 2.64B |
| Q2 FY2009 | 30 Jun 2009 | 7.74 | 20.63B | 2.67B |
| Q1 FY2009 | 31 Mar 2009 | 6.32 | 16.34B | 2.58B |
| Q4 FY2008 | 31 Dec 2008 | 4.86 | 12.46B | 2.56B |
| Q3 FY2008 | 30 Sept 2008 | 9.27 | 22.24B | 2.40B |
| Q2 FY2008 | 30 Jun 2008 | 9.15 | 20.88B | 2.28B |
| Q1 FY2008 | 21 Mar 2008 | 12.38 | 25.37B | 2.05B |
| Q4 FY2007 | 31 Dec 2007 | 18.65 | 32.76B | 1.76B |
| Q3 FY2007 | 30 Sept 2007 | 20.88 | 31.48B | 1.51B |
| Q2 FY2007 | 30 Jun 2007 | 15.31 | 18.64B | 1.22B |
| Q1 FY2007 | 31 Mar 2007 | 15.85 | 18.56B | 1.17B |
| Q4 FY2006 | 31 Dec 2006 | 16.28 | 17.75B | 1.09B |
| Q3 FY2006 | 30 Sept 2006 | 15.68 | 16.62B | 1.06B |
| Q2 FY2006 | 30 Jun 2006 | 16.82 | 17.01B | 1.01B |
| Q1 FY2006 | 31 Mar 2006 | 15.77 | 15.47B | 981.17M |
| Q4 FY2005 | 31 Dec 2005 | 13.51 | 12.67B | 937.64M |
| Q3 FY2005 | 30 Sept 2005 | 13.14 | 11.59B | 882.10M |
| Q2 FY2005 | 30 Jun 2005 | 11.86 | 10.12B | 853.10M |
| Q1 FY2005 | 31 Mar 2005 | 8.38 | 6.63B | 791.44M |
| Q4 FY2004 | 31 Dec 2004 | 10.32 | 7.77B | 752.80M |
| Q3 FY2004 | 30 Sept 2004 | 8.02 | 5.47B | 682.66M |
| Q2 FY2004 | 30 Jun 2004 | 7.70 | 4.80B | 623.23M |
| Q1 FY2004 | 31 Mar 2004 | 5.52 | 3.19B | 576.99M |
| Q4 FY2003 | 31 Dec 2003 | 4.44 | 2.38B | 536.04M |
| Q3 FY2003 | 30 Sept 2003 | 4.23 | 2.25B | 532.44M |
| Q2 FY2003 | 30 Jun 2003 | 4.33 | 2.27B | 524.83M |
| Q1 FY2003 | 31 Mar 2003 | 3.17 | 1.57B | 493.61M |
| Q4 FY2002 | 31 Dec 2002 | 3.03 | 1.42B | 469.08M |
| Q3 FY2002 | 30 Sept 2002 | 2.72 | 1.24B | 454.13M |
| Q2 FY2002 | 30 Jun 2002 | 2.90 | 1.24B | 426.34M |
| Q1 FY2002 | 31 Mar 2002 | 3.02 | 1.23B | 408.53M |
| Q4 FY2001 | 31 Dec 2001 | — | 1.23B | — |
| Q3 FY2001 | 30 Sept 2001 | — | 1.23B | — |
| Q2 FY2001 | 30 Jun 2001 | — | 1.23B | — |
Figures in USD. A quarter's revenue, net income and dividends are those of its last four quarters.
See also:P/E ratio,Market cap,Dividend yield,ROE (return on equity),Debt to equity,Current ratio,All ratios
Common questions about CME Group's P/S ratio
Source: Financial Modeling Prep